Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12624000321549
ACTRN12624000321549
Recruiting
未知

Cirrhotic Cardiomyopathy and Evaluation of Cardiovascular Risk Prediction in Patients Undergoing Liver Transplantation

ational Health and Medical Reasearch Council (NHMRC) - Post graduate scholarship0 sites200 target enrollmentMarch 25, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsiver cirrhosisCirrhotic CardiomyopathyLiver TransplantationLiver cirrhosisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCardiovascular - Other cardiovascular diseases

Overview

Phase
未知
Intervention
Not specified
Conditions
iver cirrhosis
Sponsor
ational Health and Medical Reasearch Council (NHMRC) - Post graduate scholarship
Enrollment
200
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 25, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ational Health and Medical Reasearch Council (NHMRC) - Post graduate scholarship

Eligibility Criteria

Inclusion Criteria

  • •The study population for all study arms will be drawn from the Victorian Liver Transplant Unit at Austin Health, the state\-wide service and adult liver transplant centre for Victoria and Tasmania. We will aim to prospectively recruit all adult patients (\>18 years) who are waitlisted for transplantation and/or undergo pre\-operative dobutamine stress echocardiography as part of their cardiac assessment as per usual unit protocols.

Exclusion Criteria

  • •During dobutamine stress echocardiography, patients who develop chest pain, significant ST segment changes or regional wall motion abnormalities during stress will be excluded.
  • •Patients with overt heart failure, significant valvular disease, pulmonary hypertension, amyloidosis, haemochromatosis and those on renal replacement therapy will also be excluded.
  • •Finally, patients will be excluded if an adequate retinal examination is not possible due to cataracts or narrow\-angle glaucoma.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Heart dysfunction in patients with liver cirrhosiscirrhosiscirrhotic cardiomyopathyhepatorenal syndromeCardiovascular - Other cardiovascular diseases
ACTRN12621000895886Flinders Medical Centre80
Recruiting
Not Applicable
Influence of cirrhotic cardiomyopathy on long-term outcomes and clinical findings including portal hemodynamics in cirrhosisPatients with cirrhosis
JPRN-UMIN000016566Chiba University Graduate School of Medicine160
Recruiting
Not Applicable
Cardiac Dysfunction in Patients with Fatty Liver Disease
NCT06386094Post Graduate Institute of Medical Education and Research, Chandigarh150
Unknown
Not Applicable
Prevalence, Clinical Features and Risk Factors of Cirrhotic Cardiomyopathy Assessed by Two-dimensional Speckle Tracking ImagingLiver CirrhosisCirrhotic Cardiomyopathy
NCT04969055Qilu Hospital of Shandong University200
Not yet recruiting
Not Applicable
Heart Function assessment in Liver cirrhosis PatientsHealth Condition 1: K746- Other and unspecified cirrhosis ofliver
CTRI/2020/05/025060Department of Cardiology